Johnson & Johnson Releases 2021 Health for Humanity Report Highlighting Performance on ESG Priorities and Progress Against Public Commitments Pharmaceutical Investing
Bristol Myers Squibb to Report Results for Second Quarter 2022 on July 27, 2022 Pharmaceutical Investing
Merck to Participate in the 2022 Goldman Sachs 43rd Annual Global Healthcare Conference Pharmaceutical Investing
AbbVie to Present Extensive Data from its Migraine Portfolio at the 2022 American Headache Society® Annual Scientific Meeting Pharmaceutical Investing
Bristol Myers Squibb to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference Pharmaceutical Investing
